Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Kate Young, Naureen Starling & David Cunningham. (2016) Targeting deficient DNA damage repair in gastric cancer. Expert Opinion on Pharmacotherapy 17:13, pages 1757-1766.
Read now
Read now
Taylor J Brueseke & Krishnansu S Tewari. (2013) Toll-like receptor 8: augmentation of innate immunity in platinum resistant ovarian carcinoma. Clinical Pharmacology: Advances and Applications 5:sup1, pages 13-19.
Read now
Read now
Nupur N. Gangopadhyay, James D. Luketich, Amy Opest, Carmen Visus, Ernest M. Meyer, Rodney Landreneau & Matthew J. Schuchert. (2011) Inhibition of Poly(ADP-Ribose) Polymerase (PARP) Induces Apoptosis in Lung Cancer Cell Lines. Cancer Investigation 29:9, pages 608-616.
Read now
Read now
Sheeba Irshad, Alan Ashworth & Andrew Tutt. (2011) Therapeutic potential of PARP inhibitors for metastatic breast cancer. Expert Review of Anticancer Therapy 11:8, pages 1243-1251.
Read now
Read now
Articles from other publishers (24)
Manar G. Salem, Sara A. Abu El-ata, Elsherbiny H. Elsayed, Suraj N. Mali, Hussah Abdullah Alshwyeh, Ghassan Almaimani, Riyad A. Almaimani, Hussain A. Almasmoum, Najla Altwaijry, Ebtesam Al-Olayan, Essa M. Saied & Mohamed F. Youssef. (2023) Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity. RSC Advances 13:47, pages 33080-33095.
Crossref
Crossref
Jie Zhou, Tingting Du, Xiaoyu Wang, Haiping Yao, Jialing Deng, Yan Li, Xiaoguang Chen, Li Sheng, Ming Ji & Bailing Xu. (2023)
Discovery of Quinazoline-2,4(1
H
,3
H
)-dione Derivatives Containing a Piperizinone Moiety as Potent PARP-1/2 Inhibitors─Design, Synthesis,
In Vivo
Antitumor Activity, and X-ray Crystal Structure Analysis
. Journal of Medicinal Chemistry 66:20, pages 14095-14115.
Crossref
Crossref
Michael C. Stauder. 2023.
Thanh H. Nguyen, Jeanette Stansborough, Gao J. Ong, Sven Surikow, Timothy J. Price & John D. Horowitz. (2019) Antecedent cancer in Takotsubo syndrome predicts both cardiovascular and long-term mortality. Cardio-Oncology 5:1.
Crossref
Crossref
Renu Singh, Shailly Mehrotra, Mathangi Gopalakrishnan, Ivana Gojo, Judith E. Karp, Jacqueline M. Greer, Alice Chen, Richard Piekarz, Brian F. Kiesel, Jogarao Gobburu, Michelle A. Rudek & Jan H. Beumer. (2018) Population pharmacokinetics and exposure–response assessment of veliparib co-administered with temozolomide in patients with myeloid leukemias. Cancer Chemotherapy and Pharmacology 83:2, pages 319-328.
Crossref
Crossref
Ling Deng, Qianqian Lei, Yu Wang, Zhu Wang, Guiqin Xie, Xiaorong Zhong, Yanping Wang, Nianyong Chen, Yan Qiu, Tianjie Pu, Hong Bu & Hong Zheng. (2017) Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis. Oncotarget 8:65, pages 108712-108725.
Crossref
Crossref
Wen-hua Chen, Shan-shan Song, Ming-hui Qi, Xia-juan Huan, Ying-qing Wang, Hualiang Jiang, Jian Ding, Guo-bin Ren, Ze-hong Miao & Jian Li. (2017) Discovery of potent 2,4-difluoro-linker poly(ADP-ribose) polymerase 1 inhibitors with enhanced water solubility and in vivo anticancer efficacy. Acta Pharmacologica Sinica 38:11, pages 1521-1532.
Crossref
Crossref
Wenhua Chen, Ne Guo, Minghui Qi, Haiying Dai, Minghuang Hong, Longfei Guan, Xiajuan Huan, Shanshan Song, Jinxue He, Yingqing Wang, Yong Xi, Xinying Yang, Yanyan Shen, Yi Su, Yiming Sun, Yinglei Gao, Yi Chen, Jian Ding, Yun Tang, Guobin Ren, Zehong Miao & Jian Li. (2017) Discovery, mechanism and metabolism studies of 2,3-difluorophenyl-linker-containing PARP1 inhibitors with enhanced in vivo efficacy for cancer therapy. European Journal of Medicinal Chemistry 138, pages 514-531.
Crossref
Crossref
Jie Zhou, Ming Ji, Zhixiang Zhu, Ran Cao, Xiaoguang Chen & Bailing Xu. (2017) Discovery of 2-substituted 1 H -benzo[ d ]immidazole-4-carboxamide derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors with in vivo anti-tumor activity. European Journal of Medicinal Chemistry 132, pages 26-41.
Crossref
Crossref
Kate Young & Ian Chau. (2015) Targeted Therapies for Advanced Oesophagogastric Cancer: Recent Progress and Future Directions. Drugs 76:1, pages 13-26.
Crossref
Crossref
Linhua Liu, Xiaoxuan Ling, Huanwen Tang, Jialong Chen, Qiaosheng Wen & Fei Zou. (2015) Poly(ADP-ribosyl)ation enhances H-RAS protein stability and causes abnormal cell cycle progression in human TK6 lymphoblastoid cells treated with hydroquinone. Chemico-Biological Interactions 238, pages 1-8.
Crossref
Crossref
Hongbo Chen, Xiaobin Zeng, Chunmei Gao, Pinghong Ming, Jianping Zhang, Caiping Guo, Lanzhen Zhou, Yin Lu, Lijun Wang, Laiqiang Huang, Xiangjiu He & Lin Mei. (2015) A new arylbenzofuran derivative functions as an anti-tumour agent by inducing DNA damage and inhibiting PARP activity. Scientific Reports 5:1.
Crossref
Crossref
Michael C. Stauder & Wendy A. Woodward. (2015) Local-Regional Treatment of the Patient With Inflammatory Breast Cancer. Current Breast Cancer Reports 7:1, pages 37-42.
Crossref
Crossref
Lianhua Piao, Daechun Kang, Takehiro Suzuki, Akiko Masuda, Naoshi Dohmae, Yusuke Nakamura & Ryuji Hamamoto. (2014) The Histone Methyltransferase SMYD2 Methylates PARP1 and Promotes Poly(ADP-ribosyl)ation Activity in Cancer Cells. Neoplasia 16:3, pages 257-264.e2.
Crossref
Crossref
Hongwei Peng, Xiangfei Yuan, Ruizan Shi, Xiaohua Wei, Simei Ren, Cihui Yan, Yahui Ding, Yang Lin, Dongmei Fan, Ming Yang, Yanjun Zhang & Dongsheng Xiong. (2013) PHII-7 inhibits cell growth and induces apoptosis in leukemia cell line K562 as well as its MDR- counterpart K562/A02 through producing reactive oxygen species. European Journal of Pharmacology 718:1-3, pages 459-468.
Crossref
Crossref
Na Ye, Chuan-Huizi Chen, TianTian Chen, Zilan Song, Jin-Xue He, Xia-Juan Huan, Shan-Shan Song, Qiufeng Liu, Yi Chen, Jian Ding, Yechun Xu, Ze-Hong Miao & Ao Zhang. (2013)
Design, Synthesis, and Biological Evaluation of a Series of Benzo[
de
][1,7]naphthyridin-7(8
H
)-ones Bearing a Functionalized Longer Chain Appendage as Novel PARP1 Inhibitors
. Journal of Medicinal Chemistry 56:7, pages 2885-2903.
Crossref
Crossref
Jong-Hang Chen, Cheng-Hsien Yang, Yan-Shiu Wang, Jiann-Gwu Lee, Chiung-Hsiang Cheng & Chin-Cheng Chou. (2013) Acrylamide-induced mitochondria collapse and apoptosis in human astrocytoma cells. Food and Chemical Toxicology 51, pages 446-452.
Crossref
Crossref
Zhifeng Wang, Fengli Wang, Tieshan Tang & Caixia Guo. (2012) The role of PARP1 in the DNA damage response and its application in tumor therapy. Frontiers of Medicine 6:2, pages 156-164.
Crossref
Crossref
Natalia Battista, Maria A. Meloni, Monica Bari, Nicolina Mastrangelo, Grazia Galleri, Cinzia Rapino, Enrico Dainese, Alessandro Finazzi Agrò, Proto Pippia & Mauro Maccarrone. (2012) 5‐Lipoxygenase‐dependent apoptosis of human lymphocytes in the International Space Station: data from the ROALD experiment. The FASEB Journal 26:5, pages 1791-1798.
Crossref
Crossref
Won Suk Yang, Hyeong-Gon Moon, Hee Sung Kim, Eui-Ju Choi, Myeong-Hee Yu, Dong-Young Noh & Cheolju Lee. (2011) Proteomic Approach Reveals FKBP4 and S100A9 as Potential Prediction Markers of Therapeutic Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer. Journal of Proteome Research 11:2, pages 1078-1088.
Crossref
Crossref
Rebecca S. Lamb, Matteo Citarelli & Sachin Teotia. (2011) Functions of the poly(ADP-ribose) polymerase superfamily in plants. Cellular and Molecular Life Sciences 69:2, pages 175-189.
Crossref
Crossref
Stacey L Fossey, Misty D Bear, Jiayuh Lin, Chenglong Li, Eric B Schwartz, Pui-Kai Li, James R Fuchs, Joelle Fenger, William C Kisseberth & Cheryl A London. (2011) The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines. BMC Cancer 11:1.
Crossref
Crossref
Cristina Travelli, Valentina Drago, Elena Maldi, Nina Kaludercic, Ubaldina Galli, Renzo Boldorini, Fabio Di Lisa, Gian Cesare Tron, Pier Luigi Canonico & Armando A. Genazzani. (2011) Reciprocal Potentiation of the Antitumoral Activities of FK866, an Inhibitor of Nicotinamide Phosphoribosyltransferase, and Etoposide or Cisplatin in Neuroblastoma Cells. Journal of Pharmacology and Experimental Therapeutics 338:3, pages 829-840.
Crossref
Crossref
Evelyn Yao & Andrea Ventura. (2011) A New Role for miR-182 in DNA Repair. Molecular Cell 41:2, pages 135-137.
Crossref
Crossref